Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SurVaxM (SVN53-67/M57-KLH peptide vaccine)
i
Other names:
SVN53-67/M57-KLH peptide vaccine, survivin-targeted peptide vaccine, survivin peptide mimic vaccine
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Fosun Pharma, MimiVax
Drug class:
Survivin inhibitor
Related drugs:
‹
MVP-S (3)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
NEXI-003 (0)
PDC*lung (0)
SL-701 (0)
LY2181308 (0)
MVP-S (3)
PC-002 (1)
ABBV-184 (0)
terameprocol (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
NEXI-003 (0)
PDC*lung (0)
SL-701 (0)
LY2181308 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Glioblastoma
No biomarker
Glioblastoma
SVN53-67/M57-KLH peptide vaccine
Sensitive: B - Late Trials
SVN53-67 / M57-KLH peptide vaccine
Sensitive
:
B
SVN53-67/M57-KLH peptide vaccine
Sensitive: B - Late Trials
SVN53-67 / M57-KLH peptide vaccine
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login